Qurient Co. Ltd
Qurient Co., Ltd., a biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally. The company's pipeline products include Q301, a topical 5LO inhibitor, which is in Phase II clinical trial for the treatment of atopic dermatitis; and Telacebec (Q203), Cyt bc1 Inhibitor, that is in Phase II to treat Mycobacterial Infections, such as … Read more
Qurient Co. Ltd (115180) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.062x
Based on the latest financial reports, Qurient Co. Ltd (115180) has a cash flow conversion efficiency ratio of -0.062x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.15 Billion) by net assets (₩50.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qurient Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Qurient Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Qurient Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qurient Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Philisense Tech
SHE:300287
|
-0.021x |
|
Suzhou Good-Ark Electronics Co Ltd
SHE:002079
|
0.026x |
|
Axis Real Estate Investment Trust
KLSE:5106
|
0.024x |
|
Tianneng Battery Group Co Ltd
SHG:688819
|
0.063x |
|
Sunvim Group Co Ltd
SHE:002083
|
0.023x |
|
Apollo Medical Holdings Inc
F:3AM
|
0.018x |
|
Guangdong Goworld Co Ltd
SHE:000823
|
0.049x |
|
Tellurian Inc
F:MPLN
|
-0.062x |
Annual Cash Flow Conversion Efficiency for Qurient Co. Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of Qurient Co. Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩57.60 Billion | ₩-23.32 Billion | -0.405x | +14.10% |
| 2023-12-31 | ₩46.62 Billion | ₩-21.97 Billion | -0.471x | +33.78% |
| 2022-12-31 | ₩35.14 Billion | ₩-25.00 Billion | -0.712x | -57.89% |
| 2021-12-31 | ₩54.08 Billion | ₩-24.37 Billion | -0.451x | -28.45% |
| 2020-12-31 | ₩56.57 Billion | ₩-19.85 Billion | -0.351x | +74.59% |
| 2019-12-31 | ₩17.38 Billion | ₩-24.00 Billion | -1.381x | -294.23% |
| 2018-12-31 | ₩39.41 Billion | ₩-13.80 Billion | -0.350x | +59.55% |
| 2017-12-31 | ₩14.53 Billion | ₩-12.59 Billion | -0.866x | -113.10% |
| 2016-12-31 | ₩24.35 Billion | ₩-9.90 Billion | -0.406x | +84.40% |
| 2015-12-31 | ₩2.89 Billion | ₩-7.54 Billion | -2.605x | -950.52% |
| 2014-12-31 | ₩-21.68 Billion | ₩-6.64 Billion | 0.306x | -- |